SARAH HARTZ: Open Payments
NPI 1922216829 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,250 in 19 payments from 7 companies in 2025. Trend: 2023 $1,452 · 2024 $362 · 2025 $2,250
Consulting: $1,860Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $1,860 |
| ABBVIE INC. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Alkermes, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: VRAYLAR, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA, SPRAVATO, ABILIFY ASIMTUFII, UZEDY.
Industry payments across MO — which companies pay providers there.
